Lam Research Corporation
LRCXTechnologyNASDAQSemiconductor Equipment & Materials · Last scanned Sep 9, 2026
Scan Results
Daily timeframeLam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits in the United States, China,. The $400.95B market capitalization puts LRCX squarely in mega-cap range for its industry. The company offers ALTUS systems to deposit conformal or selective films for tungsten or molybdenum metallization applications; SABRE electrochemical deposition products for copper interconnect transition, which support copper damascene manufacturing; Striker single-wafer atomic layer deposition products for dielectric film solutions; and VECTOR plasma-enhanced chemical vapor deposition (CVD) products.
Market Cap
$400.95B
Beta
1.86
P/E (TTM)
55.73
P/E (Fwd)
27.69
EPS (TTM)
$5.75
EPS (Fwd)
$11.57
ROE
65.1%
ROA
22.8%
Cash
$5.58B
Total Debt
$4.12B
Free CF
$3.09B
52W Change
186.6%
Annual Financials
Cash vs Debt
Where LRCX stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, LRCX finished 0.99% above its 150-day moving average ($285.48) and 11.26% above its 200-day moving average ($259.15). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is LRCX overbought or oversold?
At the September 3, 2026 close, LRCX's RSI(14) was 27.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $5.58B in cash and $4.12B in debt, LRCX maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Annual free cash flow of $3.09B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 65.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 22.8% further supports the picture of efficient asset utilization. Revenue has grown from $17.23B (2022) to $23.23B (2026), reflecting a 35% increase over the period.
Lam Research Corporation's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. At over 50x earnings, LRCX carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. No single metric tells the full story. Reviewing LRCX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.